These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 3755908

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Muscarinic receptor subtypes in bovine adrenal medulla.
    Aguilar JS, Ballesta JJ, Reig JA, Palmero M, Viniegra S, Criado M.
    Neurochem Res; 1992 Dec; 17(12):1235-9. PubMed ID: 1461370
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Muscarine binding sites in bovine adrenal medulla.
    Barron BA, Murrin LC, Hexum TD.
    Eur J Pharmacol; 1986 Mar 18; 122(2):269-73. PubMed ID: 3709656
    [Abstract] [Full Text] [Related]

  • 26. Muscarinic receptors in canine colonic circular smooth muscle. I. Coexistence of M2 and M3 subtypes.
    Zhang LB, Horowitz B, Buxton IL.
    Mol Pharmacol; 1991 Dec 18; 40(6):943-51. PubMed ID: 1758444
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Characterization of muscarinic receptors of the rabbit ear artery smooth muscle and endothelium.
    Hynes MR, Banner W, Yamamura HI, Duckles SP.
    J Pharmacol Exp Ther; 1986 Jul 18; 238(1):100-5. PubMed ID: 3755169
    [Abstract] [Full Text] [Related]

  • 29. [3H]Pirenzepine identifies putative M1 muscarinic receptors in human stellate ganglia.
    Watson M, Roeske WR, Johnson PC, Yamamura HI.
    Brain Res; 1984 Jan 02; 290(1):179-82. PubMed ID: 6546354
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. A unique regulatory profile and regional distribution of [3H]pirenzepine binding in the rat provide evidence for distinct M1 and M2 muscarinic receptor subtypes.
    Watson M, Yamamura HI, Roeske WR.
    Life Sci; 1983 Jun 27; 32(26):3001-11. PubMed ID: 6688111
    [Abstract] [Full Text] [Related]

  • 37. Interaction of agonists and selective antagonists with gastric smooth muscle muscarinic receptors.
    Lucchesi PA, Romano FD, Scheid CR, Yamaguchi H, Honeyman TW.
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Jun 27; 339(1-2):145-51. PubMed ID: 2498669
    [Abstract] [Full Text] [Related]

  • 38. Modulation of muscarinic cholinergic receptor affinity for antagonists in rat heart.
    Martin MW, Smith MM, Harden TK.
    J Pharmacol Exp Ther; 1984 Aug 27; 230(2):424-30. PubMed ID: 6379149
    [Abstract] [Full Text] [Related]

  • 39. Inhibition of phosphoinositide turnover by selective muscarinic antagonists in the rat striatum. Correlation with receptor occupancy.
    Monsma FJ, Abood LG, Hoss W.
    Biochem Pharmacol; 1988 Jun 15; 37(12):2437-43. PubMed ID: 2839194
    [Abstract] [Full Text] [Related]

  • 40. Characterization of M1- and M2-muscarinic receptors in calf retina membranes.
    Vanderheyden P, Ebinger G, Vauquelin G.
    Vision Res; 1988 Jun 15; 28(2):247-50. PubMed ID: 3414010
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.